FDA pharmacologic class
ARBs (angiotensin II receptor blockers)
8 medicines are in FDA's class of angiotensin 2 receptor blockers (ARBs): losartan (Cozaar), valsartan (Diovan), olmesartan (Benicar), irbesartan (Avapro), telmisartan, candesartan (Atacand), azilsartan (Edarbi) and sparsentan (Filspari); 14 combination products also contain one. 19 of the 22 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is losartan potassium 50 mg tablet at $0.0327 per tablet (NADAC).
Which medicines are arbs?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Losartan | Cozaar, Arbli | 43 labelers | $0.0327 per tablet 50 mg tablet | Yes | No current entry | 77 |
| Valsartan | Diovan, Prexxartan | 34 labelers | $0.0963 per tablet 40 mg tablet | Yes | A presentation being discontinued | 58 |
| Olmesartan | Benicar | 30 labelers | $0.0805 per tablet 20 mg tablet | Yes | No current entry | 2 |
| Hydrochlorothiazide and losartan | Hyzaar | 29 labelers | $0.0762 per tablet 100-12.5 mg tablet | Yes | No current entry | 29 |
| Hydrochlorothiazide and valsartan | Diovan | 18 labelers | $0.101 per tablet 160-12.5 mg tablet | Yes | No current entry | 23 |
| Sacubitril and valsartan | Entresto | 27 labelers | $0.533 per unit 49-51 mg | Yes | No current entry | 0 |
| Irbesartan | Avapro | 23 labelers | $0.107 per tablet 150 mg tablet | Yes | No current entry | 10 |
| Telmisartan | none listed | 28 labelers | $0.106 per tablet 20 mg tablet | Yes | No current entry | 3 |
| Hydrochlorothiazide and olmesartan | Benicar | 17 labelers | $0.165 per tablet 20-12.5 mg tablet | Yes | No current entry | 1 |
| Amlodipine and olmesartan | Azor | 14 labelers | $0.248 per unit 10-20 mg | Yes | No current entry | 6 |
| Amlodipine and hydrochlorothiazide and olmesartan | Tribenzor | 8 labelers | $0.776 per unit 20-5-12.5 | Yes | No current entry | 0 |
| Amlodipine and valsartan | Exforge | 9 labelers | $0.330 per unit 10-160 mg | Yes | No current entry | 20 |
| Candesartan | Atacand | 8 labelers | $0.478 per tablet 16 mg tablet | Yes | No current entry | 9 |
| Amlodipine and hydrochlorothiazide and valsartan | Exforge | 5 labelers | $6.09 per tablet 10-160-25 mg tablet | Yes | No current entry | 0 |
| Hydrochlorothiazide and irbesartan | Avalide | 11 labelers | $0.149 per tablet 150-12.5 mg tablet | Yes | No current entry | 8 |
| Hydrochlorothiazide and telmisartan | Micardis | 8 labelers | $0.357 per tablet 40-12.5 mg tablet | Yes | No current entry | 3 |
| Candesartan and hydrochlorothiazide | Atacand | 4 labelers | $0.954 per tablet 16-12.5 mg tablet | Yes | No current entry | 2 |
| Amlodipine and telmisartan | none listed | 3 labelers | $2.88 per unit 40-10 | Yes | No current entry | 2 |
| Azilsartan | Edarbi | 1 labeler | $5.47 per tablet 40 mg tablet | Yes | No current entry | 1 |
| Amlodipine and indapamide and telmisartan | Widaplik | none listed | n/a | Yes | No current entry | 0 |
| Azilsartan and chlorthalidone | Edarbyclor | none listed | $8.49 per tablet 40-12.5 mg tablet | Yes | No current entry | 2 |
| Sparsentan | Filspari | none listed | n/a | Yes | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price